Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
146M
-
Number of holders
-
307
-
Total 13F shares, excl. options
-
77.2M
-
Shares change
-
+2.66M
-
Total reported value, excl. options
-
$3.92B
-
Value change
-
+$126M
-
Put/Call ratio
-
0.8
-
Number of buys
-
158
-
Number of sells
-
-123
-
Price
-
$50.96
Significant Holders of RESMED INC - Common Stock (RMD) as of Q3 2015
361 filings reported holding RMD - RESMED INC - Common Stock as of Q3 2015.
RESMED INC - Common Stock (RMD) has 307 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.2M shares
of 146M outstanding shares and own 52.71% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (10.8M shares), VANGUARD GROUP INC (10M shares), BlackRock Fund Advisors (4.89M shares), STATE STREET CORP (4.29M shares), FMR LLC (4.22M shares), BlackRock Institutional Trust Company, N.A. (4.05M shares), Bank of New York Mellon Corp (2.4M shares), COMMONWEALTH BANK OF AUSTRALIA (2.06M shares), Invesco Ltd. (1.45M shares), and MACQUARIE GROUP LTD (1.43M shares).
This table shows the top 307 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.